Patents by Inventor Gordon Langsley

Gordon Langsley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8299213
    Abstract: The present invention relates to novel synthetic or natural peptides for use in treating viral or parasitic infections or in the treatment of tumors. The peptides of the present invention are less than 30 amino acids in size, preferably less than 20 amino acids, in particular 15 to 20 amino acids, and in vitro the peptides specifically bind a type 2A protein phosphatase holoenzyme or one of its subunits. The invention also relates to a method for identifying said peptides, and to their uses.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: October 30, 2012
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Alphonse Garcia, Xavier Cayla, Angelita Rebollo, Gordon Langsley
  • Publication number: 20110269674
    Abstract: The present invention relates to novel synthetic or natural peptides for use in treating viral or parasitic infections or in the treatment of tumors. The peptides of the present invention are less than 30 amino acids in size, preferably less than 20 amino acids, in particular 15 to 20 amino acids, and in vitro the peptides specifically bind a type 2A protein phosphatase holoenzyme or one of its subunits. The invention also relates to a method for identifying said peptides, and to their uses.
    Type: Application
    Filed: March 4, 2011
    Publication date: November 3, 2011
    Applicant: UNIVERSITE PARIS 6 PIERRE ET MARIE CURIE
    Inventors: ALPHONSE GARCIA, XAVIER CAYLA, ANGELITA REBOLLO, GORDON LANGSLEY
  • Publication number: 20060014930
    Abstract: The present invention relates to novel synthetic or natural peptides for use in treating viral or parasitic infections or in the treatment of tumors. The peptides of the present invention are less than 30 amino acids in size, preferably less than 20 amino acids, in particular 15 to 20 amino acids, and in vitro the peptides specifically bind a type 2A protein phosphatase holoenzyme or one of its subunits. The invention also relates to a method for identifying said peptides, and to their uses.
    Type: Application
    Filed: January 26, 2004
    Publication date: January 19, 2006
    Applicants: INSTITUT PASTEUR, Institut National de la Recherche Agronomique, CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, Centre National De La Recherche Scient.
    Inventors: Alphonse Garcia, Xavier Cayla, Angelita Rebollo, Gordon Langsley
  • Patent number: 5928901
    Abstract: The invention relates to a molecule comprising one or more peptide sequences of formula:Leu-Ala-Lys-Glu-Lys-Leu-Gln-X-Gln-Gln-Ser-Asp-Leu- Glu-Gln-Glu-Argin which X is Glu or Gly. It also relates to the utilisation of these molecules in assays and in vitro diagnostic kits for malaria on a biological sample derived from the individual in whom the disease is to be detected.
    Type: Grant
    Filed: December 3, 1996
    Date of Patent: July 27, 1999
    Assignee: Institut Pasteur
    Inventors: Claudine Marchand, Pierre Druilhe, Odile Puijalon-Mercereau, Gordon Langsley
  • Patent number: 5602031
    Abstract: The invention relates to a molecule comprising one or more peptide sequences of formula:Leu-Ala-Lys-Glu-Lys-Leu-Gln-X-Gln-Gln-Ser-Asp-Leu-Glu-Gln-Glu-Argin which X is Glu or Gly.It also relates to the utilisation of these molecules in assays and in vitro diagnostic kits for malaria on a biological sample derived from the individual in whom the disease is to be detected.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: February 11, 1997
    Assignee: Institut Pasteur
    Inventors: Claudine Marchand, Pierre Druilhe, Odile Puijalon-Mercereau, Gordon Langsley
  • Patent number: 5599542
    Abstract: The invention relates to a molecule comprising one or more peptide sequences of formula:Leu-Ala-Lys-Glu-Lys-Leu-Gln-X-Gln-Gln-Ser-Asp-Leu-Glu-Gln-Glu-Argin which X is Glu or Gly.It also relates to the utilization of these molecules in assays and in vitro diagnostic kits for malaria on a biological sample derived from the individual in whom the disease is to be detected.
    Type: Grant
    Filed: October 6, 1988
    Date of Patent: February 4, 1997
    Assignee: Institut Pasteur
    Inventors: Claudine Marchand, Pierre Druilhe, Odile Puijalon-Mercereau, Gordon Langsley
  • Patent number: 5589343
    Abstract: The invention relates to a molecule comprising one or more peptide sequences of formula:Leu-Ala-Lys-Glu-Lys-Leu-Gln-X-Gln-Gln-Ser-Asp-Leu-Glu-Gln-Glu-Argin which X is Glu or Gly.It also relates to the utilisation of these molecules in assays in vitro diagnostic kits for malaria on a biological sample derived from the individual in whom the disease is to be detected.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 31, 1996
    Assignee: Institut Pasteur
    Inventors: Claudine Marchand, Pierre Druilhe, Odile Puijalon-Mercereau, Gordon Langsley